https://clinicaltrials.gov/ct2/show/NCT03905525?type=Intr&cond=Sjogren%27s+Syndrome&lupd_s=10%2F14%2F2019&lupd_d=14&sort=nwst
STUDY TITLE:
Study of Safety and Efficacy of Multiple Doses of CFZ533 in Two Distinct Populations of Patients With Sjögren’s Syndrome
DESCRIPTION:
Condition: Sjögren Syndrome
Interventions: Drug: CFZ533; Other: Placebo
Sponsor: Novartis Pharmaceuticals
Recruiting
CLINICALTRIALS.GOV IDENTIFIER:
NCT03905525
FIRST POSTED:
Fri, 05 Apr 2019 12:00:00 EDT
LAST UPDATE POSTED:
10/28/19 11:40AM
STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT03905525?type=Intr&cond=Sjogren%27s+Syndrome&lupd_s=10%2F14%2F2019&lupd_d=14&sort=nwst
